Jake_young2016-07-22 11:10
$ZS Pharm(ZSPH)$ 和$Relypsa(RLYP)$ 都被收了,时间长波动大没把握住。下一个会是$Depomed(DEPO)$ 吗?查看全文
二遍水2016-05-10 21:15
这是之前写的一篇文章,已经发表在生物谷。
Relypsa, 会是下一个并购对象吗?
Relypsa创立于2007年,位于加州RedWood(大名鼎鼎的Oracle的总部就位于此)。公司主要从事非吸收聚合类药物的开发和商业化,专注于肾脏和代谢性疾病领域,其核心技术为高分子聚合物的开发技术平台。
2013年9月...查看全文
ddzan2016-04-08 00:55
$RELYPSA(RLYP)$ 买到了~虽然不多——Relypsa working with Centerview Partners to review offers from potential buyers -- Reuters, citing sources查看全文
淡投2016-02-23 06:59
M: $爱力根医疗(AGN)$
T: $Intercept Pharmaceuticals(ICPT)$
W: $RELYPSA(RLYP)$ $Sage Therapeutics(SAGE)$
T: $阿尔凯默斯(ALKS)$ $塞德斯医疗(CLDX)$ $Clovis Oncology(CLVS)$
F: $爱美医疗(FOLD)$查看全文
美股实战学院2016-01-08 14:20
个股关注:做空股逢高:$史密斯威森(SWHC)$ (看情况)$SunEdison(SUNE)$ KMI $RELYPSA(RLYP)$ $阿卡迪亚(ACAD)$ $晶科能源(JKS)$ 动能股逢低买:$德纳维制药(DVAX)$ $花旗(C)$ $500彩票网(WBAI)$ $uniQure(QURE)$ BIOC HTBX Netflix(NFLX) 反弹股:LL LEI $苹果(AAPL)$ SWHC RGG(看情况)
具...查看全文
$Relypsa(RLYP)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2016-08-09 AccNo: 0001193125-16-676070 Size: 13 KB 网页链接
$Relypsa(RLYP)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2016-08-09 AccNo: 0001193125-16-676066 Size: 26 KB 网页链接
$Relypsa(RLYP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-08-08 AccNo: 0001193125-16-675332 Size: 214 KB 网页链接
$Relypsa(RLYP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-04 AccNo: 0001564590-16-022735 Size: 8 MB 网页链接
$Relypsa(RLYP)$ SC 14D9 - Solicitation, recommendation statements Filed: 2016-08-04 AccNo: 0001193125-16-671841 Size: 1 MB 网页链接
$Relypsa(RLYP)$ SC TO-T - Tender offer statement by Third Party Filed: 2016-08-04 AccNo: 0001193125-16-671782 Size: 1 MB 网页链接
$Relypsa(RLYP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-07-28 AccNo: 0000947871-16-001369 Size: 162 KB 网页链接
$Relypsa(RLYP)$ 内部交易: 2016-07-25,10% Owner,ORBIMED ADVISORS LLC ,卖出,343600普通股, $31.98
$Relypsa(RLYP)$ 内部交易: 2016-07-22,10% Owner,ORBIMED ADVISORS LLC ,卖出,3700000普通股, $32.00
$Relypsa(RLYP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-07-26 AccNo: 0000947871-16-001363 Size: 166 KB 网页链接